title: Implanted protection. Women slowly turn to Norplant use.
authors.forename: G
authors.initials: G
authors.lastname: Kobren
mesh_terms: D000569:Americas; D003267:Contraception; D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D019049:Developed Countries; D004467:Economics; D005193:Family Planning Services; D005376:Financial Management; D006297:Health Services Accessibility; D007348:Insurance, Health; D016912:Levonorgestrel; D008396:Maryland; D009656:North America; D009934:Organization and Administration; D015397:Program Evaluation; D013812:Therapeutics; D014481:United States
chemical_list: D003270:Contraceptive Agents; D003271:Contraceptive Agents, Female; D016912:Levonorgestrel
keywords: Americas; Contraception; Contraceptive Agents, Female--contraindications; Contraceptive Agents, Progestin--contraindications; Contraceptive Agents--contraindications; Contraceptive Implants--cost; Contraceptive Methods--cost; Contraceptive Mode Of Action; Developed Countries; Economic Factors; Family Planning; Financial Activities; Health Insurance; Insertion; Levonorgestrel--contraindications; Maryland; North America; Northern America; Organization And Administration; Program Accessibility; Program Evaluation; Programs; Reversibility; Treatment; United States